Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

BSLK vs ECVT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ECVT Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 7–3 Matrix Metrics)

ECVT Overall Winner 6-Pillar Tally: BSLK 0 – 6 ECVT Matrix Metrics: BSLK 3 – 7 ECVT

As of Nov 16, 2026, Ecovyst Inc. (ECVT) is the stronger overall head-to-head candidate over Bolt Projects Holdings, Inc. (BSLK) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BSLK carries a Unified Composite Score of 41.2/100 (SELL) at $0.58 (N/M Forward P/E, -1179.5% operating margin), whereas ECVT carries 37.3/100 (SELL) at $10.56 (12.1x Forward P/E, 9.7% operating margin).

  • Composite vs. Pillar Nuance: While BSLK currently prints a higher short-term Unified Composite Score (41.2/100 SELL vs. ECVT 37.3/100 SELL), ECVT captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (9.7% vs. -1179.5% operating margin) and revenue trajectory (+50.6% vs. +7300.0% YoY).
  • Defensive Composite Rating Caution: Although ECVT compares more favorably head-to-head, both BSLK (41.2/100 SELL) and ECVT (37.3/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: BSLK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 19.8); meanwhile ECVT is in a Breakdown options structure phase (RSI 58.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BSLK vs ECVT
BSLK NASDAQ
Bolt Projects Holdings, Inc. Common Stock
Industrial Organic Chemicals
$0.58
-27.01% 1D
Market Cap $7.1M
TTM Revenue $3.1M
Forward P/E N/M
Beta / 30D Vol 4.04β · 148% Vol
Unified Composite Score
41.2 / 100 SELL
Tech 40.0 Fund 43.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -29.4%), weak momentum, RSI 20
RSI-14: 19.8 · SMA20: $1.63 · SMA50: $1.95
ECVT NYSE Head-to-Head Winner
Ecovyst Inc.
Chemicals & Allied Products
$10.56
-3.74% 1D
Market Cap $1.2B
TTM Revenue $973M
Forward P/E 12.1x
Beta / 30D Vol 0.31β · 26% Vol
Unified Composite Score
37.3 / 100 SELL
Tech 18.0 Fund 34.0 Flow 66.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 58
RSI-14: 58.1 · SMA20: $10.27 · SMA50: $10.22

6-Pillar Scorecard Institutional Category Breakdown (BSLK 0 – 6 ECVT)

Columns: Metric · BSLK · ECVT
1. Valuation Multiples ECVT
Forward P/E N/M 12.1x
Trailing P/E 0.1x 28.1x
PEG Ratio N/M N/M
EV / Revenue 4.9x 1.7x
2. Growth & Scale ECVT
Revenue Growth (YoY) +7300.0% +50.6%
Earnings Growth (YoY) +0.0% +48.9%
TTM Revenue (USD) $3.1M $973M
Market Cap $7.1M $1.2B
3. Profitability & Quality ECVT
Gross Margin 3.2% 19.7%
Operating Margin -1179.5% 9.7%
Net Profit Margin 0.0% 3.7%
Return on Equity (ROE) -4288.3% 7.2%
4. Balance Sheet & Cash Flow ECVT
Cash Generation (TTM) -$5.4M $27M
Cash Flow Margin N/A 2.8%
Net Cash / Leverage $8.2M Net Debt $473M Net Debt (0.90x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ECVT
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) 42.9% (16th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown ACCUMULATION · Neutral
6. R&D & Supply-Chain Moat ECVT
OpEx & R&D Intensity N/A 10.0% of Rev ($97M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Specialty Chemicals Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BSLK (3) vs ECVT (7)
Institutional Metric BSLK ECVT Criterion Row Edge
Market Capitalization
Scale
$7.1M $1.2B Larger Scale ECVT
Trailing P/E Ratio
Valuation
0.1x 28.1x Lower Multiple BSLK
Forward P/E Ratio
Valuation
N/M 12.1x Lower Multiple ECVT
Revenue Growth (YoY)
Growth
+7300.0% +50.6% Higher Growth BSLK
Operating Margin (TTM)
Profitability
-1179.5% 9.7% Higher Margin ECVT
Net Profit Margin
Profitability
0.0% 3.7% Higher Margin ECVT
Return on Equity (ROE)
Capital Efficiency
-4288.3% 7.2% Higher ROE ECVT
52-Week Range Position
Momentum
0% ($1–$25) 35% ($8–$15) Stronger Trend ECVT
Beta / 30D Volatility
Risk Regime
4.04β · 148% Vol 0.31β · 26% Vol Lower Realized Risk ECVT
Unified Institutional Score
Composite Signal
41.2 / 100 (SELL) 37.3 / 100 (SELL) Higher Composite BSLK
Trailing 12M Revenue (USD)
Operating Scale
$3.1M $973M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
3.2% 19.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 4.9x EV/Rev N/M PEG · 1.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$5.4M ($8.2M Net Debt) $27M ($473M Net Debt (0.90x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ECVT +83.47 pp
BSLK: -73.85% · ECVT: +9.62%
3M Horizon ECVT +84.84 pp
BSLK: -69.47% · ECVT: +15.37%
6M Horizon ECVT +84.84 pp
BSLK: -69.47% · ECVT: +15.37%
1Y Horizon ECVT +84.84 pp
BSLK: -69.47% · ECVT: +15.37%

Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant USD Revenue & Operating Margin (%)
Period BSLK Revenue ECVT Revenue BSLK Op. Margin ECVT Op. Margin Margin Leader
Q4 '24 $10M N/A -504.4% N/A BSLK
Q1 '25 $0M N/A -3157.9% N/A BSLK
Q2 '25 $10M N/A -370.0% N/A BSLK
Q3 '25 $0M $820M -1179.5% 16.7% ECVT
Q4 '25 N/A $800M N/A 12.8% ECVT
Q1 '26 N/A $860M N/A 6.9% ECVT
Q2 '26 N/A $1.00B N/A 12.1% ECVT
Q3 '26 N/A $1.23B N/A 11.2% ECVT

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BSLK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BSLK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ECVT BREAKDOWN
128d in phase · OBV ACCUMULATION
Current IV 42.9%
IV Percentile 16th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact ECVT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BSLK Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $7.1M market capitalization and -1179.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ECVT Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $1.2B market capitalization and 9.7% operating margin.
OpEx & R&D Reinvestment 10.0% of Rev ($97M)
90D Engineering Disclosures 0 Published

Investor FAQ BSLK vs ECVT Key Questions & Quantitative Answers

As of Nov 16, 2026, Ecovyst Inc. (ECVT) is the stronger overall head-to-head candidate over Bolt Projects Holdings, Inc. (BSLK) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BSLK carries a Unified Composite Score of 41.2/100 (SELL) at $0.58 (N/M Forward P/E, -1179.5% operating margin), whereas ECVT carries 37.3/100 (SELL) at $10.56 (12.1x Forward P/E, 9.7% operating margin). Composite vs. Pillar Nuance: While BSLK currently prints a higher short-term Unified Composite Score (41.2/100 SELL vs. ECVT 37.3/100 SELL), ECVT captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (9.7% vs. -1179.5% operating margin) and revenue trajectory (+50.6% vs. +7300.0% YoY). Defensive Composite Rating Caution: Although ECVT compares more favorably head-to-head, both BSLK (41.2/100 SELL) and ECVT (37.3/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: BSLK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 19.8); meanwhile ECVT is in a Breakdown options structure phase (RSI 58.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ECVT leads the Growth & Scale pillar: BSLK posts +7300.0% YoY revenue growth and +0.0% YoY earnings growth on $3.1M TTM revenue (3.2% gross margin, -1179.5% operating margin), compared with ECVT at +50.6% YoY revenue growth and +48.9% YoY earnings growth on $973M TTM revenue (19.7% gross margin, 9.7% operating margin). Across the 8-period historical trajectory (Q4 '24 to Q3 '26), BSLK cumulative revenue shifted +0.0% while ECVT shifted +50.0%. In operating R&D and SG&A reinvestment, BSLK deploys N/A (0 90-day corporate R&D disclosures) versus 10.0% of Rev ($97M) (0 disclosures) for ECVT.

ECVT screens cheaper on headline valuation multiples. BSLK trades at N/M Forward P/E, 0.1x Trailing P/E, N/M PEG, and 4.9x EV/Revenue (unreported FCF margin), whereas ECVT trades at 12.1x Forward P/E, 28.1x Trailing P/E, N/M PEG, and 1.7x EV/Revenue (2.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BSLK (-4288.3% ROE) versus ECVT (7.2% ROE) capital efficiency.

In options market volatility and institutional positioning, BSLK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.04β · 148% Vol realized risk). By comparison, ECVT carries 42.9% implied volatility (16th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (0.31β · 26% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.